Article
Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
Neuroscience letters - 28 Feb 2005
Mellick George D, Maraganore Demetrius M, Silburn Peter A
Abstract excerpt
It remains unclear whether genetic variants in SNCA (the alpha-synuclein gene) alter risk for sporadic Parkinson's disease (PD). The polymorphic mixed sequence repeat (NACP-Rep1) in the promoter region of SNCA has been previously examined as a potential susceptibility factor for PD with conflicti...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
